The clinical trial is intended to assess for clinical evidence of Clemastine Fumarate as a myelin repair therapy in patients with chronic inflammatory injury-c…

Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more

~Estimated

~$10 – $5,625

University of California, San FranciscoNCT05359653

Development of Camera Based Gait Deviation Index for Persons With Multiple Sclerosis

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis Relapse+1 more

~Estimated

~$10 – $1,125

Shirley Ryan AbilityLabNCT06516458